Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells?
Saved in:
| Title: | Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells? |
|---|---|
| Authors: | Sebe A; Paul-Ehrlich-Institut, Langen, Germany. attila.sebe@pei.de., Hernani R; Hematology Department, Hospital Clínico Universitario INCLIVA Biomedical Research Institute, Valencia, Spain., Müller-Berghaus J; Paul-Ehrlich-Institut, Langen, Germany. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2026 Jun; Vol. 18 (6), pp. 2007-2011. Date of Electronic Publication: 2026 Apr 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42045678 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sebe+A%22">Sebe A</searchLink>; Paul-Ehrlich-Institut, Langen, Germany. attila.sebe@pei.de.<br /><searchLink fieldCode="AU" term="%22Hernani+R%22">Hernani R</searchLink>; Hematology Department, Hospital Clínico Universitario INCLIVA Biomedical Research Institute, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Müller-Berghaus+J%22">Müller-Berghaus J</searchLink>; Paul-Ehrlich-Institut, Langen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101487380%22">EMBO molecular medicine</searchLink> [EMBO Mol Med] 2026 Jun; Vol. 18 (6), pp. 2007-2011. <i>Date of Electronic Publication: </i>2026 Apr 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22EMBO+Press%22">EMBO Press </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101487380 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-4684 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217574676%22">17574676 </searchLink><i>NLM ISO Abbreviation: </i>EMBO Mol Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42045678 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s44321-026-00436-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2007 Titles: – TitleFull: Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sebe A – PersonEntity: Name: NameFull: Hernani R – PersonEntity: Name: NameFull: Müller-Berghaus J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1757-4684 Numbering: – Type: volume Value: 18 – Type: issue Value: 6 Titles: – TitleFull: EMBO molecular medicine Type: main |
| ResultId | 1 |